New Asthma Diagnosis Codes or Short‐Acting <i>β</i><sub>2</sub> Agonist Prescriptions After Histoplasmosis Among Patients With Commercial Health Insurance, United States, 2018–2023
These findings suggest that histoplasmosis may predispose certain patients to airway hyperreactivity, particularly those with acute pulmonary symptoms. Further research is needed to elucidate potential mechanisms underlying these findings, which could inform strategies to mitigate post-infectious airway disease in affected patients.
Authors
- Ian Hennessee (ORCID: https://orcid.org/0000-0001-8807-9566)
- Nicolas Barros (ORCID: https://orcid.org/0000-0002-8531-3537)
- Dallas J. Smith (ORCID: https://orcid.org/0000-0001-5707-528X)
- Kaitlin Benedict (ORCID: https://orcid.org/0000-0003-0458-2493)
Institutions
- Centers for Disease Control and Prevention (US)
- Indiana University School of Medicine
- Indiana University – Purdue University Indianapolis (US)
Publication Details
- Journal
- Mycoses
- Published
- 2025-09-01
- DOI
- https://doi.org/10.1111/myc.70109
- Primary Topic
- Antifungal resistance and susceptibility
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Centers for Disease Control and Prevention